Prognostic value of calcium score and coronary flow velocity reserve in asymptomatic diabetic patients by Miodrag Dikic et al.
RESEARCH Open Access
Prognostic value of calcium score and
coronary flow velocity reserve in
asymptomatic diabetic patients
Miodrag Dikic1*, Milorad Tesic1, Zeljko Markovic2,3, Vojislav Giga1,2, Ana Djordjevic-Dikic1,2, Jelena Stepanovic1,2,
Branko Beleslin1,2, Ivana Jovanovic1, Ana Mladenovic3, Jelena Seferovic2,4, Miodrag Ostojic2
and Aleksandra Arandjelovic2,5
Abstract
Background: The risk stratification of patients with diabetes mellitus (DM) is a major objective for the clinicians, and
it can be achieved by coronary flow velocity reserve (CFVR) or with coronary artery calcium score (CS). CS evaluates
underlying coronary atherosclerotic plaque burden and CFVR estimates both presence of coronary artery stenosis and
microvascular function. Consequently, CFVR may provide unique risk information beyond the extent of coronary
atherosclerosis.
Aim: Our aim is to assess joint prognostic value of CFVR and CS in asymptomatic DM patients.
Materials and methods: We prospectively included 200 asymptomatic patients (45,5 % male, mean age 57,35 ± 11,25),
out of which, there were 101 asymptomatic patients with DM and 99 asymptomatic patients without DM, but with one
or more conventionally risk factors for coronary artery disease. We analyzed clinical, biochemical, metabolic, inflammatory
parameters, CS by Agatston method, transthoracic Doppler echocardiography CFVR of left anterior descending artery
and echocardiographic parameters.
Results: Total CS and CS LAD were significantly higher, while mean CFVR was lower in diabetics compared to the
nondiabetics. During 1 year follow-up, 24 patients experienced cardio-vascular events (one cardiovascular death, two
strokes, three myocardial infarctions, nine new onsets of unstable angina and nine myocardial revascularizations): 19
patients with DM and five non DM patients, (p = 0,003). Overall event free survival was significantly higher in non DM
group, compared to the DM group (94,9 % vs. 81,2 %, p = 0,002 respectively), while the patients with CS≥200 and
CFVR <2 had the worst outcome during 1 year follow up in the whole study population as well as in the DM group.
At multivariable analysis CFVR on LAD (HR 12.918, 95 % CI 3.865–43.177, p < 0.001) and total CS (HR 13.393, 95 % CI
1.675–107.119, p = 0.014) were independent prognostic predictors of adverse events in DM group of patients.
Conclusion: Both CS and CFVR provide independent and complementary prognostic information in asymptomatic DM
patients. When two parameters are analyzed together, the risk stratification ability improves, even when DM patients are
analyzed together with non DM patients. As a result, DM patients with CS≥200 and CFVR <2 had the worst outcome.
Consequently, the use of two tests identified subset of patients who can derive the most benefit from the intensive
prevention measures.
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Introduction
The leading cause of mortality in patients with diabetes is
coronary artery disease (CAD). Patients with diabetes mel-
litus (DM) have increased risk of myocardial infarction
and cardiovascular death due to accelerated coronary ath-
erosclerosis, thus the risk stratification of DM patients is a
major objective for the clinicians [1]. Traditional cardio-
vascular risk factors such as age, systolic blood pressure,
smoking, cholesterol levels and family history can’t com-
pletely account for the increased cardiovascular mortality
in patients with diabetes [2]. Also novel additional factors
like inflammatory factors (fibrinogen, C-reactive protein,
Galectin-3) and metabolic factor (lipoproteins) could con-
tribute in explanation of atherosclerosis in diabetes [3–5].
Patients with DM are often asymptomatic until the
onset of acute coronary event [6] and they have a poor
prognosis [7]. Risk stratification of DM patients with un-
known or suspect CAD can be achieved by stress echo-
cardiography [8–13], coronary flow reserve [14–17], or
with coronary artery calcium score (CS) [18, 19].
Coronary flow velocity reserve (CFVR) reflects both -
the presence of epicardial coronary artery stenosis and
function of microcirculation [20–22]. Impaired CFVR in
DM patients is occasionally observed in the absence of
significant epicardial coronary arteriosclerosis, even in
young adults with DM type I of shorter duration without
associated CAD [8, 14, 16, 22].
CS has emerged as promising tool for CAD risk assess-
ment [18]. The amount of CS on cardiac computed tom-
ography has been found to correlate with a total coronary
atherosclerotic burden and the risk of adverse cardiovas-
cular outcomes [19]. Recent large prospective study dem-
onstrated that the CS is significant independent predictor
of cardiovascular events and can enhance the predictive
power of traditional cardiovascular risk factors in asymp-
tomatic patients with diabetes [19]. On the other hand,
with the CS result should be cautious since, compared to
the computed tomography angiography, it can miss non-
calcified plaque components [19].
CS evaluates underlying coronary atherosclerotic plaque
burden and CFVR estimates both presence of coronary ar-
tery stenosis and microvascular function. Consequently,
CFVR may provide unique risk information beyond the
extent of coronary atherosclerosis. Thus, our aim is to as-




We prospectively included 200 asymptomatic patients
(45,5 % male, mean age 57,35 ± 11,25), from October 2012
to the March 2013. Out of 200 patients, there were 101
asymptomatic patients with DM diagnosed by standard
criteria and on standard diabetic therapy, including diet,
tablets, or insulin and 99 asymptomatic patients without
DM, but with one or more conventionally risk factors for
coronary artery disease.
Patients with a prior history of CAD (including hospital
admission for chest pain, acute coronary syndromes, stable
angina or prior coronary revascularization) or any other
heart disease were excluded from the study in both groups.
Also criteria for exclusion from the study were as follows:
poor echocardiographic window for CFVR assessment,
chronic obstructive pulmonary artery disease, atrioven-
tricular block, inability to provide informed consent.
We pooled biochemical, metabolic parameters (choles-
terol, low-density lipoprotein, high-density lipoprotein,
triglycerides, glucose level, hemoglobin A1c (HbA1c),
microalbuminuria, inflammatory markers of atheroscler-
osis (high sensitive C reactive protein and fibrinogen).
CFVR of left anterior descending artery (LAD) and multi
slice computed tomography (MSCT) of coronary arteries
with CS calculation according to Agatston method [23]
were done in all patients.
Echocardiography and coronary flow velocity reserve
Echocardiographic studies were performed with an
available digital ultrasound system (Acuson Sequoia
C256; Siemens Medical Solutions USA, Inc, Mountain
View, CA).
To visualize distal part of LAD artery we used modi-
fied, foreshortened, three chamber view, obtained by
sliding the 3V2C multifrequency (4-MHz) transducer on
the upper part and medially from an apical three cham-
ber view [20, 24]. For color-Doppler flow mapping, the
velocity range was set to the range of 16–24 cm/sec.
Alignment of the ultrasound beam direction with the
distal LAD flow was kept as parallel as possible. All the
subjects had Doppler recordings of the LAD at rest and
during intravenously slow application of adenosine
(0.14 mg/kg/min), during 2 min. By placing the sample
volume on the color signal, spectral Doppler of the LAD
showed the characteristic biphasic flow pattern (larger
diastolic and smaller systolic components). Coronary
diastolic peak velocities were measured at baseline and
during the intravenous infusion of adenosine by aver-
aging three consecutive Doppler signals for each meas-
urement. CFVR was defined as ratio of hyperemic and
baseline diastolic peak velocities [20, 22, 24]. Digital im-
ages were obtained and stored on magneto-optical discs
and analyzed offline by two well trained physicians.
Calcium score assessment
All study participants agreed and underwent serial cor-
onary artery CS assessment using MSCT (SOMATOM
Sensation 64, Siemens Medical Solutions, Forchheim,
Germany) scanner. Heart images view obtained with
100 ms scan time, using 3 mm slices, starting at the level
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of carina and proceeding to the level of diaphragm (40–45
slices). Tomography imaging was electrocardiographically
triggered at 40 % or 65 % of the R-R interval, depending
on the subject’s heart rate. CS was defined as a plaque of
at least 2 pixels (area 0.67 mm2) with density ≥130
Hounsfield units. Quantitative CS was calculated using
Agatston method [23], which involves the multiplication
of the area of calcified focus by a cofactor based on the
peak density of the lesion. The total CS calculation was
done by adding the individual scores of the all lesions
found along the entire coronary artery tree [23]. Then, ac-
cording to the total CS results, patients were grouped into
the five CS categories: 0–10, 11–100, 101–400, 401–1000,
and >1000 Agatston units, as previously used [19, 25].
Standard invasive coronary angiography was recom-
mended to selected patients according to the current
Guidelines by the referred physician. All diagnostic pro-
cedures were done at Clinic for cardiology and Clinic for
radiology of Clinical Center of Serbia.
Informed consents were obtained for all the participants;
the study was in adherence to the tents of Declaration of
Helsinki and the local ethical committee approved the
study protocol.
Follow-up data
During a 1 year follow up of the patients; outcomes were
determined from patient interviews at the outpatient
clinic, hospital chart reviews, and telephone interviews
with patients, their close relatives, or referring physician.
Cardiovascular death, stroke, nonfatal myocardial infarc-
tion, new onset of unstable angina and clinically driven
percutaneous coronary intervention (PCI), or coronary by-
pass grafting (CABG) were registered as clinical events.
Diagnosis of death from cardiovascular causes were ob-
tained from the results of postmortem examination and
detailed hospital documentation. Myocardial infarction
was defined by typical symptoms, electrocardiographic
and cardiac enzyme changes, while stroke was defined as
rapid onset of focal or global neurological deficit lasting
≥24 h or leading to death, with clinical findings supple-
mented by neurological imaging. Unstable angina was di-
agnosed on the basis of clinical features of an acute
coronary syndrome without diagnostic enzyme changes or
need for hospital admission or both. Follow-up data were
analyzed for the prediction of composite endpoint of
major adverse cardiovascular and cerebrovascular events
(MACCE).
Statistical analyses
Descriptive statistics were used to summarize baseline
demographic, biochemical and clinical characteristics, and
risk factors in two groups - DM and non DM group.
Categorical variables were compared using chi-square test.
Continuous variables were compared by using Simple T-
test, and/or ANOVA-test, or Kruskal Wallis test (for vari-
ables without normal distribution). Statistical correlation
among CS and CFVR was examined with the Spearman’s
correlation coefficient. Survival rates were estimated with
Kaplan-Meier curves and compared by the log-rank test.
The association of selected variables with outcome was
assessed with the Cox proportional hazard model using
univariate and stepwise multivariate procedures. A signifi-
cance of 0.05 was required for a variable to be included
into the multivariate model, whereas 0.1 was the cut off
value for exclusion. Hazard ratios with the corresponding
95 % confidence intervals were estimated. The sensitivity
and specificity of CFVR and CS for outcome prediction
were evaluated with receiver operating characteristic
curves. Analyses were performed using SPSS for Windows
version 22 (SPSS, Inc, Chicago, IL).
Results
Demographic, biochemical and clinical characteristics of
the study population were presented in Table 1. Mean
age of the whole study population was 57,7 ± 11,84 years
(60,34 ± 10,21 years in diabetic and 55,04 ± 12,81 years
in non diabetic group, p < 0.001). Subjects were obese
with mean body mass index 27,39 ± 4,73 kg/m2 (28,74 ±
4,68 kg/m2 in DM group and 26,01 ± 4,39 kg/m2 in non
DM group, p < 0.001). Average systolic blood pressure
for the whole population was 128,03 ± 11,44 mmHg
(130,10 ± 11,27 mmHg in DM group and 125,91 ±
11,28 mmHg in non DM group, p = 0,009).
There were no significant differences between DM and
non DM group in gender, prevalence of smoking and
family history of cardiovascular disease, level of choles-
terol, low-density lipoproteins, high sensitive C-reactive
protein and fibrinogen level (Table 1). Diabetic patients
had significantly more often hypertension, microalbumi-
nuria, higher systolic blood pressure, lower level of
HDL, higher level of triglycerides, glucose, HbA1C
(Table 1).
CFVR and CS parameters were presented in Table 2.
There were no differences between groups in baseline and
hyperemic velocities of LAD, but mean value of CFVR
was significantly lower in DM group (p = 0,011). The per-
cent of patients with pathological values of CFVR <2 was
significantly higher in diabetics compared to the nondia-
betics (18,8 % vs. 3,0 %, p < 0,001, respectively). Total CS
and CS LAD were significantly higher in diabetics com-
pared to the non DM group. In our study there was sig-
nificantly higher rate of CS 0–100 in non diabetics (74,8 %
vs. 44,6 %), while higher rate of CS ≥401 was found in dia-
betics (20,8 % vs. 5,0 %). In subgroup of patients with cut
off of CS ≥200 Agatston units there was significantly
higher rate of diabetics compared to non diabetics (44,6 %
vs.15,2 %, p < 0,001 respectively).
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There were significant correlations between CFVR
LAD and total CS (r = −0,266, p = 0.008) as well as with
CS of LAD artery (r = −0,249, p = 0.013) in DM patients.
CFVR and CS did not correlate significantly in non DM
patients. There was also no relation between HbA1c and
CFVR of LAD in our DM population.
During 1 year follow-up, 24 patients (12 %) experienced
cardio-vascular events: 19 patients with DM (17,8 %) and
five patients (5,1 %) in non DM group,(p = 0,003), Table 3.
When we analyzed type of events, there were signifi-
cantly higher number of PCIs in diabetic group com-
pared to non diabetic group (31,6 % vs. 20 %, p = 0,050
respectively). There were no significant differences in
death, MI, CABG and onset of angina between two
groups. Using a receiver operating characteristic analysis,
CFVR = 2 and CS = 200 were the best predictors of future
events (area under the curve = 0,801, sensitivity = 66,7 %,
specificity = 83,0 % and area under the curve = 0,928, sen-
sitivity = 91,7 %, specificity = 79,2 %, respectively) and were
taken as cut off values for the further statistics.
Overall event free survival was significantly higher in
non DM group, compared to the DM group (94,9 % vs.
81,2 %, p = 0,002 respectively),as presented in Fig. 1, while
the patients with CS ≥200 and CFVR <2 had the worst out-
come during 1 year follow up in the whole study popula-
tion (Fig. 2), as well as in the DM group (Fig. 3).
In the whole study population patients with CS ≥200 and
CFVR <2 had a 24,3 fold increase in cardiovascular risk
compared to the patients with CS <200 and CFVR ≥2 (95 %
CI: 5,13–106,97; p < 0.001), while in the DM group, patients
with CS ≥200 and CFVR <2 had 43,7 fold increase in car-
diovascular risk compared to the patients with CS <200 and
CFVR ≥2 (95 % CI: 7,09–269,77; p < 0,001).
Univariate predictors of MACCE are reported in Table 4.
At multivariable analysis CFVR on LAD (HR 12.918, 95 %
CI 3.865–43.177, p < 0.001) and total CS (HR 13.393, 95 %
CI 1.675–107.119, p = 0.014) were independent prognostic
predictors of MACCE in DM group of patients as pre-
sented in Table 4.
Discussion
This study, represents the results of the annual follow up
regarding the prognostic value of CS and CFVR in asymp-
tomatic diabetic patients, where abnormal CFVR <2, de-
tected by Doppler echocardiography identified together
with CS ≥200 subset of patients at higher risk for adverse
Table 1 Demographic, biochemical and clinical characteristics of the study population
Variables Non DM DM Total p value: non
DM vs. DM(n = 99) (n = 101) (n = 200)
Male, no. (%) 42 (42,4 %) 49 (48,5 %) 91 (45,5 %) p = 0,387
Age 55,04 ± 12,81 60,34 ± 10,21 57,7 ± 11,84 p < 0,001
Obesity BMI ≤25 52 (52,5 %) 20 (19,8 %) 72 (36,0 %) p < 0,001
BMI >25 47 (47,5 %) 81 (80,2 %) 128 (64,0 %)
BMI (kg/m2) 26,01 ± 4,39 28,74 ± 4,68 27,39 ± 4,73 p < 0,001
Smoking History, no. (%) Current 28 (28,2 %) 19 (18,8 %) 47 (23,5 %) p = 0,261
Former 16 (16,2 %) 21 (20,8 %) 37 (18,5 %)
Non smoker 55 (55,56 %) 61 (60,40 %) 116 (58,00 %)
Family history, no. (%) 65 (65,70 %) 70 (69,30 %) 135 (67,50 %) p = 0,582
HTA, no. (%) 54 (55,70 %) 86 (85,10 %) 140 (70,70 %) p < 0,001
Systolic blood pressure (mmHg) 125,91 ± 11,28 130,10 ± 11,27 128,03 ± 11,44 p = 0,009
Hypercholesterolemia, no. (%) 52 (53,1 %) 72 (72 %) 124 (62,6 %) p = 0,006
Cholesterol (mmol/l) 5,54 ± 0,93 5,36 ± 0,91 5,45 ± 0,92 p = 0,160
LDL (mmol/l) 3,40 ± 0,87 3,26 ± 0,81 3,33 ± 0,84 p = 0,253
HDL (mmol/l) 1,38 ± 0,33 1,19 ± 0,26 1,28 ± 0,31 p < 0,001
Triglycerides (mmol/l) 1,52 ± 0,80 2,10 ± 1,12 1,82 ± 1,02 p < 0,001
Glucose (mmol/l) 5,37 ± 0,74 8,31 ± 2,76 6,86 ± 2,51 p < 0,001
HbA1C (%) 5,51 ± 0,81 7,13 ± 1,32 6,33 ± 1,36 p < 0,001
CRP (mg/l) 2,13 ± 1,71 2,89 ± 3,47 2,51 ± 2,77 p = 0,141
Fibrinogen (g/l) 3,63 ± 1,04 3,58 ± 1,05 3,61 ± 1,05 p = 0,734
Microalbuminuria, no. (%) 0 (0,00 %) 26 (25,7 %) 26 (13,0 %) p < 0,001
Plus–minus values are means ± SD, BMI body mass index, CRP C-reactive protein, DM diabetes mellitus, LDL low-density lipoprotein, HDL high-density lipoprotein,
HbA1C hemoglobin A1c, HTA hypertension
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Table 3 Major adverse cardiac and cerebrovascular events, calcium score and coronary flow velocity reserve in patients with and
without diabetes mellitus
Non DM DM Total % p value: non
DM vs DM(n = 99) (n = 101) (n = 200)
Number % Number % Number
MACCE No 94 94,9 % 82 81,2 % 176 88 % p = 0,003
Yes 5 5,1 % 19 18,8 % 24 12 %
CS/MACCE 0–199 1 20 % 1 5,3 % 2 8,3 % p = 0,289
≥200 4 80 % 18 94,7 % 22 91,7 %
CFVR/MACCE CFVR <2 1 20 % 15 78,9 % 16 66,7 % p = 0,013
CFVR ≥2 4 80 % 4 21.1 % 8 33,3 %
Events Death 0 0,0 % 1 5,3 % 1 4,2 % p = 0,321
MI 1 20 % 2 10,5 % 3 12,5 % p = 0,573
PCI 1 20 % 6 31,6 % 7 29,2 % p = 0,050
CABG 0 0,0 % 2 10,5 % 2 8,3 % p = 0,159
Stroke 1 20 % 1 5,3 % 2 8,3 % p = 0,989
Unstable Angina 2 40 % 7 36,8 % 9 37,5 % p = 0,987
Mean follow-up –months 15,44 ± 3,38 14,14 ± 5,95
(14,46–17,84) (12,96–15,32)
Overall survival 94,9 % ± 2,2 % 81,2 % ± 3,8 %
Plus–minus values are means ± SD, CS calcium score, CFVR coronary flow velocity reserve, DM diabetes mellitus, MACCE major adverse cardiac and cerebrovascular
event, MI myocardial infarction, PCI percutaneous coronary intervention, CABG coronary arteries bypass grafting
Table 2 Coronary flow velocity reserve and calcium score parameters
Variables Non DM DM Total p value: non
DM vs. DM(n = 99) (n = 101) (n = 200)
Baseline diastolic flow velocity (m/sec), LAD 0,27 ± 0,05 0,27 ± 0,07 0,27 ± 0,06 p = 0,663
Hyperemic diastolic flow velocity (m/sec), LAD 0,72 ± 0,16 0,67 ± 0,19 0,70 ± 0,18 p = 0,061
Rest heart rate 71,27 ± 10,86 70,70 ± 9,11 70,98 ± 10,0 p = 0,687
Hyperemic heart rate 76,23 ± 12,36 75,23 ± 10,82 76,06 ± 11,58 p = 0,835
CFVR 2,65 ± 0,41 2,48 ± 0,44 2,56 ± 0,44 p = 0,011
CFVR <2 3 (3,0 %) 19 (18,8 %) 22 (11,0 %) p < 0,001
CFVR ≥2 96 (97,0 %) 82 (81,2 %) 178 (89,0 %)
CS - total 93,10 ± 196,59 322,76 ± 534,84 209,09 ± 419,56 p < 0,001
CS - LAD 46,16 ± 93,24 142,32 ± 232,88 96,24 ± 184,40 p < 0,001
CS, no. (%) 0–10 56 (56,6 %) 31 (30,7 %) 87 (43,5 %) p < 0,001
11–100 18 (18,2 %) 14 (13,9 %) 32 (16,0 %)
101–400 20 (20,2 %) 35 (34,6 %) 55 (27,5 %)
401–1000 3 (3,0 %) 14 (13,9 %) 17 (8,5 %)
≥1001 2 (2,0 %) 7 (6,9 %) 9 (4,5 %)
CS 0–199 84 (84,8 %) 56 (55,4 %) 140 (70,0 %) p < 0,001
CS ≥200 15 (15,2 %) 45 (44,6 %) 60 (30,0 %)
Plus–minus values are means ± SD, DM diabetes mellitus, LAD left anterior descending artery, CS calcium score, CFVR coronary flow velocity reserve, CVD
cardiovascular disease
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events. When the two parameters are analyzed together,
the risk stratification ability improves, even when DM pa-
tients are analyzed together with non DM patients. Thus,
our data confirms and expands previous studies, suggest-
ing not only that CFVR and CS have prognostic value
when separately analyzed but also that the combination of
the two parameters has additive value and that they are
complementary in their power of prediction. In our study,
we found that older male as well as obese patients, mostly
diabetics, have higher level of CS. At the same time,
asymptomatic diabetic patients had significantly higher both
total CS and CS of LAD artery compared to the control
group which is consistent with published studies [25–27].
The presence of diabetes carries a higher risk, and
studies have shown that CS 0 can be helpful to stratifi-
cate these subjects into the low-risk category, with a
lower rate of adverse events and excellent survival. In
asymptomatic individuals with DM, prevalence of CS 0
in patients without diabetes was twice as high as com-
pared to the subjects with diabetes with the same CS, as
similar to our study, but there was no difference in sur-
vival during 5 years follow up (98.8 % vs. 99.4 %, p = 0,5)
Fig. 1 Kaplan-Meier event-free survival curve in patients with and without diabetes mellitus. DM: diabetes mellitus
Fig. 2 Kaplan-Meier event-free survival curve in diabetic and non diabetic patients stratified according to the presence of CS <200 or CS ≥200 and
CFVR <2 or CFVR ≥2. The worst survival is observed in patients with CS ≥200 and CFVR <2. CS: calcium score, CFVR: coronary flow velocity reserve
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[25]. Meta-analysis of 18 studies showed that CS 0 had a
negative predictive value of 93 % for the presence of ob-
structive CAD, suggesting that CS 0 can safely exclude
presence of obstructive CAD [28]. Other studies also
showed that patients with CS = 0, have very low risk of
cardiac events during the follow-up as well as in our
study [29, 30]. In the study with asymptomatic DM pa-
tients during 8-years follow-up, it was presented that the
CS over 400 had a significantly higher prevalence of
cardiovascular events compared to the group with lower
CS (5.6 % vs. 0.7 %, p < 0.01) [31]. It was also shown,
that CS increased in proportion to an adverse events
from 0 to 18 % when the score rised from 100 to 1000
Agatston units [31]. We presented that diabetics with
CS ≥200 had more often MACCE, which is consistent
with the results of published studies [31, 32]. Prediction
of adverse cardiovascular events in asymptomatic DM
patients compared according to the value of CS and
Fig. 3 Kaplan-Meier event-free survival curve in diabetic patients stratified according to the presence of CS <200 or CS ≥200 and CFVR <2 or
CFVR ≥2. The worst survival is observed in patients with CS ≥200 and CFVR <2. CS: calcium score, CFVR: coronary flow velocity reserve
Table 4 Univariate and multivariate prognostic predictors of adverse events in diabetic patient
Univariate analysis Multivariate analysis
HR 95.0 % CI for HR p HR 95.0 % CI for HR p
Lower Upper Lower Upper
Gender (male) 4,365 1,448 13,162 0,009 1,431 0,455 4,498 0,539
Age 1,863 0,671 5,173 0,233
Obesity 0,970 0,322 2,925 0,958
HTA 1,602 0,370 6,937 0,528
Family history of CAD 0,948 0,360 2,494 0,913
Smoking habit 0,891 0,351 2,263 0,808
Hypercholesterolemia 2,533 1,028 6,239 0,043 1,149 0,441 2,990 0,777
Microalbuminuria 1,713 0,674 4,351 0,258
CRP 1,503 0,604 3,736 0,381
Fibrinogen 1,100 0,447 2,706 0,863
CS (≥200<) 26,707 3,559 200,381 0,001 13,393 1,675 107,119 0,014
CFVR (≥2<) 24,240 7,944 73,970 <0,001 12,918 3,865 43,177 <0,001
CRP C-reactive protein, HTA hypertension, CS calcium score, CFVR coronary flow velocity reserve, CAD coronary artery disease, HR hazard ratio, CI
confidence interval
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followed during 4 years, was recently presented in pro-
spective cohort study [19]. Authors analyzed classical risk
factors, as well as metabolic and inflammatory factors
(lipoprotein, apolipoprotein, homocysteine and C-reactive
protein) [19]. They showed that the CS is independent
predictor of the cardiovascular events [19]. We also
analyzed inflammation (CRP and fibrinogen), and
metabolic (glycated hemoglobin, hypercholesterolemia
and microalbuminuria) parameters but we found that
the CFVR and CS were the only independent predic-
tors of adverse events.
As previously showed, we found that CFVR LAD was
significantly lower in DM group compared to the non
DM group [14, 15, 22]. Nemes et al. determined the
prognostic impact of diabetes and CFVR in patients with
suspected coronary artery disease. During 41 ± 12 months
they recorded 22 cardiovascular deaths (13 sudden car-
diac death, seven acute heart failure, two had cardiovas-
cular thrombosis) [17]. Multivariable regression analysis
showed that only CFVR and DM were independent pre-
dictors of cardiovascular survival [17]. According to the
ROC analysis, the best predictive value of CFVR was
1.73 [17]. In contrast to this study, our study examined
asymptomatic patients with and without diabetes and
had only one death of DM patient during the shorter
follow up, while the best predictor value of CFVR for
the adverse events was two. Cortigiani et al. furthermore
point out importance of evaluation of microcirculation
in DM patients without severe CAD (≤50 % diameter
coronary stenosis), where CFVR ≤2 represented a strong
and independent predictor of the combined event of
death and nonfatal MI predicting a nearly seven times
higher yearly hard-event rate compared with preserved
CFVR [14]. In the same study, nonobstructive CAD
failed to provide independent prognostic contribution,
although it was associated with significantly lower mean
CFVR [14].
Reduced CFVR in DM patients without coronary artery
disease is due to functional and structural changes of cor-
onary microcirculation [33–35]. It is also known that cor-
onary microcirculatory dysfunction can reduce CFVR,
even without inducing regional wall motion abnormalities
or before the occurrence of coronary artery stenosis, but
can still be linked with adverse events in patients with
DM or LV hypertrophy [8, 9, 14, 24]. Microvascular dys-
function affects LV globally [14], thus the CFVR LAD is
excellent option for evaluation of microcirculation due to
high feasibility (94–98 %) in various studies [8, 14, 20, 24].
Therefore we found that in asymptomatic DM pa-
tients the assessment of CFVR as a marker of func-
tion of both micro- and macro-circulation together
with evaluation of coronary morphology by CS is a
reasonable diagnostic method for the risk stratifica-
tion of adverse coronary events.
Study limitations
There were some limitations in our study. First we en-
rolled asymptomatic diabetic patients, and asymptomatic
controls according to their anamnestic data that they
don’t have any anginal symptoms and fatigue. Our study
is relatively small, because there were just 200 subjects
enrolled out of which 101 DM patients. Also we did not
have age matched control group, but we believe that
eventhough the age was significantly different between
groups that difference cannot affect significantly values
of CFVR and CS [36]. Although measurement of CFVR
in all three coronary arteries is preferable, CFVR was
measured only in the LAD due to technical challenge in
the present time to visualize all three coronary arteries
with high feasibility [24]. We didn’t focus on diastolic
dysfunction, which is reported in diabetes, and leads to
the impaired CFVR as well as hypertension. However in
both groups we had patients with hypertension, which
contributed to the results of CFVR in both groups.
Conclusion
Both CS and CFVR obtained by MSCT and by transtho-
racic Doppler echocardiography assessments, respectively,
provide independent and complementary prognostic in-
formation in asymptomatic DM patients. When the two
parameters are analyzed together, the risk stratification
ability improves, even when DM patients are analyzed to-
gether with non DM patients. As a result, DM patients
with CS ≥200 and CFVR <2 had the worst outcome. Con-
sequently, the use of two tests identified subset of patients
who can derive the most benefit from the intensive pre-
vention measures - more aggressive control of the risk fac-
tors and more frequent follow-up by noninvasive testing.
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